APA (7th ed.) Citation

Mitzlaff, K., Kirstein, M., Müller, C., Venerito, M., Olkus, A., Dill, M. T., . . . Zimpel, C. (2024). Efficacy, safety and differential outcomes of immune-chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: A multicenter real world cohort. United european gastroenterology journal, 12(9), . https://doi.org/10.1002/ueg2.12656

Chicago Style (17th ed.) Citation

Mitzlaff, Katharina, et al. "Efficacy, Safety and Differential Outcomes of Immune-chemotherapy with Gemcitabine, Cisplatin and Durvalumab in Patients with Biliary Tract Cancers: A Multicenter Real World Cohort." United European Gastroenterology Journal 12, no. 9 (2024). https://doi.org/10.1002/ueg2.12656.

MLA (9th ed.) Citation

Mitzlaff, Katharina, et al. "Efficacy, Safety and Differential Outcomes of Immune-chemotherapy with Gemcitabine, Cisplatin and Durvalumab in Patients with Biliary Tract Cancers: A Multicenter Real World Cohort." United European Gastroenterology Journal, vol. 12, no. 9, 2024, https://doi.org/10.1002/ueg2.12656.